Circulation ResearchImmunologyPeer-reviewed journal article
The intestinal microbiota contributes to the development of immune-mediated cardiovascular inflammation and vasculitis in mice.
Prasant Kumar JenaiD, Daiko Wakita, Angela C. GomeziD, Thacyana Teixeira de CarvalhoiD, Asli E. AticiiD, Emily A. AubuchoniD, Meena NarayananiD, Youngho LeeiD, Michael C. FishbeiniD, Yoshihiro TakasatoiD, Yosuke KurashimaiD, Hiroshi KiyonoiD, Patrice D. CaniiD, Willem M. de VosiD, David M. UnderhilliD, Suzanne DevkotaiD, Shuang CheniD, Kenichi ShimadaiD, Timothy R. CrotheriD, Moshe ArditiiD, Magali Noval RivasiD
- Citations
- 25
- FWCI
- 23.43
- Field percentile
- top 1%
Abstract
Alterations in the intestinal microbiota contribute to the pathogenesis of various cardiovascular disorders, but how they affect the development of Kawasaki disease (KD), an acute pediatric vasculitis, remains unclear. We report that depleting the gut microbiota reduces the development of cardiovascular inflammation in a murine model mimicking KD vasculitis. The development of cardiovascular lesions was associated with alterations in the intestinal microbiota composition and, notably, a decreased abundance of Akkermansia muciniphila and Faecalibacterium prausnitzii. Oral supplementation with either of these live or pasteurized individual bacteria, or with short-chain fatty acids (SCFAs) produced by them, attenuated cardiovascular inflammation. Treatment with Amuc_1100, the TLR-2 signaling outer membrane protein from A. muciniphila, also decreased the severity of vascular inflammation. This study reveals an underappreciated gut microbiota-cardiovascular inflammation axis in KD vasculitis pathogenesis and identifies specific intestinal commensals that regulate vasculitis in mice by producing metabolites or via extracellular proteins acting on gut barrier function. IN BRIEFIt remains unclear whether changes in the intestinal microbiota composition are involved in the development of cardiovascular lesions associated with Kawasaki disease (KD), an immune-mediated vasculitis. Jena et al. observe alterations in the intestinal microbiota composition of mice developing vasculitis, characterized by reduced A. muciniphila and F. prausnitzii. Oral supplementation with either of these bacteria, live or pasteurized, or with bacteria-produced short-chain fatty acids (SCFAs) or Amuc_1100, the TLR-2 signaling outer membrane protein of A. muciniphila, was sufficient to alleviate the development of cardiovascular lesions in mice by promoting intestinal barrier function. HIGHLIGHTSO_LIAbsence or depletion of the microbiota decreases the severity of vasculitis in a murine model mimicking KD vasculitis. C_LIO_LISupplementation of B. wadsworthia and B. fragilis promotes murine KD vasculitis. C_LIO_LIDecreased abundances of F. prausnitzii and A. muciniphila are associated with the development of cardiovascular lesions in mice. C_LIO_LISupplementation with either live or pasteurized A. muciniphila and F. prausnitzii, or the TLR-2 signaling Amuc_1100, reduces the severity of vasculitis by promoting gut barrier function. C_LI
- organism: mouse
- assay: proteomics
- assay: metagenomics
- research focus: host-pathogen & immune response
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell-cell communication
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Sirtuin 1 Activation Mitigates Murine Vasculitis Severity by Promoting Autophagy and Mitophagy
Asli E. Atici, Prasant Kumar Jena, … Magali Noval Rivas·bioRxiv·Sep 4, 2025
- Progression of vascular function and blood pressure in a mouse model of Kawasaki disease
M. Delvecchio, J. V. Alves, … T. Bruder-Nascimento·bioRxiv·Aug 25, 2022
- Spatial profiling of Kawasaki disease cardiac inflammation identifies STING as a therapeutic target
B. Evan Ross, Asli E. Atici, … Magali Noval Rivas·bioRxiv·Oct 22, 2026
- The IL-1β - BHLHE40 Axis in the Pathogenesis of Kawasaki Disease: Insights from Cell-Type-Specific Expression Analysis
Sho Ishigaki, Tatsuya Koreeda, Hiroshi Honda·bioRxiv·Sep 3, 2026
- Circulating miR-10b-5p drives Kawasaki vasculitis through endothelial reprogramming and nominates CXCL8 as an early diagnostic biomarker
Sunyoung Park, Gaeun Kang, … Gwang Hyeon Eom·bioRxiv·Mar 16, 2026
- mTOR signaling controls the formation of smooth muscle cell-derived intimal fibroblasts during vasculitis.
A. Stock, S. Parsons, … I. P. Wicks·bioRxiv·Dec 15, 2023